These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 993596)

  • 1. Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis.
    Ertl HC; Koszinowski UH
    J Immunol; 1976 Dec; 117(6):2112-8. PubMed ID: 993596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of early viral surface antigens in cellular immune response to vaccinia virus.
    Koszinowski U; Ertl H
    Eur J Immunol; 1976 Oct; 6(10):679-83. PubMed ID: 65141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. III. Enzyme sensitivity of target cell antigens.
    Todd RF
    Cell Immunol; 1975 Dec; 20(2):257-68. PubMed ID: 1203988
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated cytotoxicity against Sendai-virus-infected cells.
    Ertl H; Koszinowski U
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):128-40. PubMed ID: 60844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
    Brutkiewicz RR; Klaus SJ; Welsh RM
    Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
    Berke G; McVey E; Hu V; Clark WR
    J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductive requirements for the generation of virus-specific T lymphocytes. III. Production of target cells lysable by poxvirus-specific and allospecific cytotoxic T lymphocytes with membrane fragments bearing viral and H-2 antigens.
    Hapel AJ; Bablanian R; Cole GA
    J Immunol; 1980 Apr; 124(4):1997-2003. PubMed ID: 6154088
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic removal of H-2 alloantigens from the surface of P815-(X2) mouse tumor cells.
    Thomas K; Engers HD; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Apr; 6(4):257-62. PubMed ID: 825372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.
    Gardner I; Bowern NA; Blanden RV
    Eur J Immunol; 1974 Feb; 4(2):63-7. PubMed ID: 4211857
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of alterations induced by early vaccinia surface antigens and dependence of virus-specific lysis on H-2 antigen concentration on target cells.
    Koszinowski U; Ertl H; Wekerle H; Thomssen R
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 2():529-37. PubMed ID: 302176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autochthonous, allogeneic, and exenogeneic cells as targets for vaccinia immune lymphocyte cytotoxicity.
    Woan MC; Yip DM; Tompkins WA
    J Immunol; 1978 Jan; 120(1):312-6. PubMed ID: 627720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells.
    Senik A; Neauport-Sautes C
    J Immunol; 1979 Apr; 122(4):1461-7. PubMed ID: 448095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of immunoglobulin receptors and antibody-dependent cell cytotoxicity (ADCC) in rat lymphoid organs.
    Kedar E; Ortiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):37-46. PubMed ID: 4130151
    [No Abstract]   [Full Text] [Related]  

  • 18. Diversity of T cells recognizing transplantation antigens: mechanism of antigen recognition.
    Wekerle H; Lanai P; Feldman M
    Transplant Proc; 1973 Mar; 5(1):133-6. PubMed ID: 4144457
    [No Abstract]   [Full Text] [Related]  

  • 19. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.
    Koszinowski U; Ertl H
    Nature; 1975 Jun; 255(5509):552-4. PubMed ID: 1079922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.